Table 3.
Hospital course
| Control group (n = 843) | HBcAb+ organ recipients (n = 25) | P-value | |
|---|---|---|---|
| Operative time, h, median (range) | 6.6 (3.3–14.4) | 6.1 (3.7–10.8) | 0.15a |
| Operative time, h, mean ± SD | 6.8 ± 1.7 | 6.3 ± 1.8 | |
| PRBC in OR, units, median (range) | 3 (0–42) | 4 (0–37) | 0.52a |
| PRBC in OR, units, mean ± SD | 5.2 ± 6.2 | 6.0 ± 7.2 | |
| WIT, min, median (range) | 35 (15–80) | 33 (18–48) | 0.08a |
| WIT, min, mean ± SD | 36 ± 8.4 | 33 ± 6.9 | |
| ICU stay, days, median (range) | 2 (1–121) | 2 (1–12) | 0.93a |
| ICU stay, days, mean ± SD | 5.9 ± 12 | 5.7 ± 12 | |
| Hospital stay, days, median (range) | 7 (6–145) | 7 (4–56) | 0.67a |
| Hospital stay, days, mean ± SD | 11.5 ± 12.9 | 12.6 ± 12.5 | |
a
Unpaired t-test, two-tailed P-value.
HBcAb+, hepatitis B core antibody-positive; SD, standard deviation; PRBC, packed red blood cells; OR, operating room; WIT, warm ischaemic time; ICU, intensive care unit.